WHI-P258

CAS No. 21561-09-1

WHI-P258 ( WHI-P258; WHI-P 258; WHI-P-258; WHIP 258 )

Catalog No. M13440 CAS No. 21561-09-1

WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 46 In Stock
10MG 72 In Stock
25MG 140 In Stock
50MG 224 In Stock
100MG 377 In Stock
500MG 861 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WHI-P258
  • Note
    Research use only, not for human use.
  • Brief Description
    WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3.
  • Description
    WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3. This compound binds JAK3 weakly and may be used as a JAK binding negative control in the development of new therapeutics.
  • Synonyms
    WHI-P258; WHI-P 258; WHI-P-258; WHIP 258
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR; JAK3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    21561-09-1
  • Formula Weight
    281.31
  • Molecular Formula
    C16H15N3O2
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: <1.2mg/mL
  • SMILES
    COC1=CC2=NC=NC(NC3=CC=CC=C3)=C2C=C1OC
  • Chemical Name
    6,7-Dimethoxy-N-phenylquinazolin-4-amine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Fry DW, et al. Science. 1994, 265(5175), 1093-1095.
molnova catalog
related products
  • HKI-357

    HKI-357 is an irreversible dual inhibitor of EGFR and ERBB2 (IC50s: 34 nM and 33 nM). HKI-357 suppresses EGFR autophosphorylation (at Y1068), and AKT and MAPK phosphorylation.

  • Gefitinib hydrochlor...

    A potent, selective, orally active EGFR inhibitor with IC50 of 23 nM.

  • CO-1686

    A potent, highly selective, irreversible inhibitor of mutant EGFR with Ki of 21.5 nM for EGFR L858R/T790M.